What are Cannaceuticals? (The Great Cannabis Medicine Race)

What are Cannaceuticals – The Great Cannabis Medicine Race Israel has long been the forerunner of medical cannabis research. Some of the most significant and interesting studies are coming from this small middle-eastern country. They brought us studies on cannabis and bone health, cancer research, neuropathic pain and much more.…

Continue reading

Canadian Company Working On Cannabis Medicine For Rare Form Of Skin Cancer

Canadian Company Working On Cannabis Medicine For Rare Form Of Skin Cancer Patent-Pending Medicine Being Tested In Israel   Cutaneous T-cell lymphoma (CTCL) is one of the rarest forms of skin cancer. It affects the T-lymphocyte, also known as T-Cell, which is a kind of white blood cell that helps…

Continue reading

First cannabis-based medicine approved by FDA arrives in the U.S.

For the first time, a marijuana-based medicine approved by federal regulators is available for prescription in the United States. The medicine, called Epidiolex, is used to treat seizures related to Lennox-Gastaut and Dravet syndromes, two forms of epilepsy, which is a neurological disorder, according to a news release. “Because these…

Continue reading

Whole Plant Medicine Better Than CBD For Epilepsy, Says New Research

Whole Plant Medicine Better Than CBD For Epilepsy, Says New Research There is no doubt that medicinal cannabis is effective in addressing epilepsy, one of the most well-studied conditions that cannabis can treat. In particular, cannabidiol (CBD), has received much attention for its breakthrough abilities to treat epilepsy especially in…

Continue reading

Cannabis As Medicine Still Faced With Resistance From US Doctors

Cannabis As Medicine Still Faced With Resistance From US Doctors …and what you can do if your doctor won’t recommend cannabis According to the Institute of Medicine of the National Academies, there are around 100 million Americans who suffer from pre-approved conditions requiring cannabis as medicine. But not all patients…

Continue reading

GW Pharmaceuticals’ CEO talks Epidiolex, future of cannabidiol medicine

This is a make-or-break spring for GW Pharmaceuticals and its billion-dollar investment in a cannabidiol-based drug. The London-based firm aims to develop the first FDA-approved medicine from plant-derived cannabis compounds. The U.S. Food and Drug Administration could decide as early as June 27 whether Epidiolex, a CBD oral solution, could be…

Continue reading